Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Giacomelli

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Rheumatology|July 10, 2002
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro studyR Giacomelli, P Cipriani, M Matucci Cerinic, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
Journal of Internal Medicine|January 14, 2015
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort studyE Bartoloni, C Baldini, G Schillaci, et al.
Clinical and Experimental Immunology|August 21, 2016
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patientsG Guggino, F Ciccia, D Di Liberto, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosisM Manetti, V Liakouli, C Fatini, et al.
Lupus|November 5, 2003
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control studyR Priori, E Medda, F Conti, et al.
Clinical and Experimental Immunology|July 7, 2017
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patientsG Guggino, M Lo Pizzo, D Di Liberto, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Risk factors for Sjögren's syndrome: a case-control studyR Priori, E Medda, F Conti, et al.
Clinical and Experimental Immunology|April 17, 2015
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18F Ciccia, G Guggino, A Rizzo, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Rheumatology|July 10, 2002
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro studyR Giacomelli, P Cipriani, M Matucci Cerinic, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
Journal of Internal Medicine|January 14, 2015
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort studyE Bartoloni, C Baldini, G Schillaci, et al.
Clinical and Experimental Immunology|August 21, 2016
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patientsG Guggino, F Ciccia, D Di Liberto, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosisM Manetti, V Liakouli, C Fatini, et al.
Lupus|November 5, 2003
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control studyR Priori, E Medda, F Conti, et al.
Clinical and Experimental Immunology|July 7, 2017
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patientsG Guggino, M Lo Pizzo, D Di Liberto, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Risk factors for Sjögren's syndrome: a case-control studyR Priori, E Medda, F Conti, et al.
Clinical and Experimental Immunology|April 17, 2015
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18F Ciccia, G Guggino, A Rizzo, et al.
Pageof 8